<DOC>
	<DOCNO>NCT00325676</DOCNO>
	<brief_summary>The aim study evaluate complete remission rate , endoscopic relapse , study discontinuation rate , quality life parameter patient erosive GERD . The study duration consist treatment period 16 week accord classical healing concept complete remission concept . During period , patient receive pantoprazole ( tablet ) one dose level daily . The following observational phase last 6 month . The study provide data efficacy , safety , tolerability pantoprazole .</brief_summary>
	<brief_title>Comparison Classical Healing Concept With Complete Remission Concept After Treatment With Pantoprazole Adult Patients With Erosive GERD ( Gastroesophageal Reflux Disease ) ( BY1023/M3-342 )</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>Main Written inform consent Endoscopically confirm GERD ( Los Angeles classification AD ) Patients whose compliance expect high respect completion questionnaire Main Other gastrointestinal disease Severe concomitant diseases Proton pump inhibitor ( PPIs ) last 14 day start H2 receptor antagonist , prokinetics last 7 day study start Helicobacter pylorus ( H. pylorus ) eradication last 28 day study start</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>GERD</keyword>
	<keyword>Pantoprazole</keyword>
	<keyword>Complete Remission</keyword>
</DOC>